These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15838569)
21. The role of endothelial dysfunction to predict the development of allograft coronary artery disease following cardiac transplantation. Mudge GH; Yeung A; Selwyn AP; Ganz P Trans Am Clin Climatol Assoc; 1992; 103():105-10. PubMed ID: 1413370 [No Abstract] [Full Text] [Related]
22. [Coronary allograft vasculopathy: pathophysiological interaction between the immune system, infections and metabolic syndrome]. Potena L; Ferrara R; Mocarski ES; Lewis DB; Cooke JP; Grigioni F; Coccolo F; Magnani G; Fallani F; Magelli C; Valantine HA; Branzi A G Ital Cardiol (Rome); 2007 Feb; 8(2):73-82. PubMed ID: 17402351 [TBL] [Abstract][Full Text] [Related]
34. Proliferation signal inhibitors and cardiac allograft vasculopathy. Raichlin E; Kushwaha SS Curr Opin Organ Transplant; 2008 Oct; 13(5):543-50. PubMed ID: 19060540 [TBL] [Abstract][Full Text] [Related]
35. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production. Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360 [TBL] [Abstract][Full Text] [Related]
36. Vascular immunoobliterative disease: a common cause of graft failure. Reemtsma K Transplant Proc; 1989 Aug; 21(4):3706. PubMed ID: 2669281 [No Abstract] [Full Text] [Related]
37. Elevated donor troponin levels are associated with a lower frequency of allograft vasculopathy. Miller WL; Edwards BS; Kremers WK; Kushwaha SS; McGregor CG; Daly RC; Jaffe AS J Heart Lung Transplant; 2005 Dec; 24(12):2075-8. PubMed ID: 16364852 [TBL] [Abstract][Full Text] [Related]